Nanjing, China

Qi Peng

This inventor holds 1 USPTO granted patent. Top assignee: Nanjing Noratech Pharmaceuticals Co., Ltd. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qi Peng. Retrieved from https://idiyas.com/inventor/qi-peng-0u4imjza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qi Peng - Innovator in Pharmaceutical Formulation

Introduction

Qi Peng is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical formulation, particularly in the development of injectable medications. His work focuses on improving the efficacy and stability of drug formulations.

Latest Patents

Qi Peng holds a patent for an "Aripiprazole injectable suspension formulation having prolonged shelf life." This invention is crucial in the treatment of schizophrenia and related diseases. The formulation not only enhances the shelf life of aripiprazole but also provides a reliable method for its administration.

Career Highlights

Qi Peng is associated with Nanjing Noratech Pharmaceuticals Co., Ltd., where he applies his expertise in pharmaceutical sciences. His innovative approach has led to advancements in drug formulation, benefiting patients and healthcare providers alike.

Collaborations

Qi Peng has worked alongside talented colleagues such as Yunzhe Sun and Cheng-Gang Lin. Their collaborative efforts contribute to the ongoing research and development in the pharmaceutical industry.

Conclusion

Qi Peng's contributions to pharmaceutical formulation exemplify the impact of innovation in healthcare. His work continues to pave the way for improved treatment options for patients suffering from schizophrenia and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…